Quince Therapeutics Inc (NAS:QNCX)
$ 1.055 -0.005 (-0.47%) Market Cap: 45.59 Mil Enterprise Value: -15.44 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 38/100